ghk-cu tolerance desensitization receptor downregulation Diosgenin promoted OPCs differentiation via blocking GLUR2/GAPDH interaction in a pilocarpine rat model of epilepsy ghk-cu tolerance desensitization antibody formation – ghk-cu tolerance ghk-cu tolerance desensitization loss of

The peptide is not approved by the FDA or other health authorities as a drug or dietary supplement

No completed randomized controlled human trial

Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by [PMID: 4400818] Laboratory literature summary: Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase

Nothing here is medical advice, a therapeutic claim, or a dosing recommendation for human use

The peptide is believed to help extend telomere lengths, supporting healthy aging and longevity in humans

DSIP has not reached that level for common uses such as insomnia, stress, recovery, or withdrawal support